P3.02b-039 Analysis of Prognostic Factor for Afatinib Treated Patients with EGFR Mutation Positive NSCLC

التفاصيل البيبلوغرافية
العنوان: P3.02b-039 Analysis of Prognostic Factor for Afatinib Treated Patients with EGFR Mutation Positive NSCLC
المؤلفون: Shuji Murakami, Akimasa Sekine, Terufumi Kato, Kouzo Yamada, Tetsuro Kondo, Saki Manabe, Masafumi Sata, Haruhiro Saito, Takashi Ogura
المصدر: Journal of Thoracic Oncology. 12:S1210-S1211
بيانات النشر: Elsevier BV, 2017.
سنة النشر: 2017
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Prognostic factor, medicine.medical_specialty, Egfr mutation, business.industry, Afatinib, Internal medicine, medicine, business, medicine.drug
تدمد: 1556-0864
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a41ac23062ad14f59baa045f1b56d068Test
https://doi.org/10.1016/j.jtho.2016.11.1706Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........a41ac23062ad14f59baa045f1b56d068
قاعدة البيانات: OpenAIRE